Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles

The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world’s leading cause of disability, in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceutics
Päätekijät: Vilella, Antonietta, Ruozi, Barbara, Belletti, Daniela, Pederzoli, Francesca, Galliani, Marianna, Semeghini, Valentina, Forni, Flavio, Zoli, Michele, Vandelli, Maria Angela, Tosi, Giovanni
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2015
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491652/
https://ncbi.nlm.nih.gov/pubmed/26102358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics7020074
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia